The Urgo Medical Group today inaugurated the extension of its Veauche plant in the Saint-Etienne area. An investment of 30 million euros over 10 years, intended to respond to the strong development of the brand and its compression bands, hems and woven in Veauche. The French manufacturer of medical textile (head office in Dijon in Burgundy) has made the bet of "made in France" and innovation. This year, a school set up in partnership with PôleEmploi and the Maya Campus in Roanne will host 8 internships in the heart of the factory.
The Urgo laboratories, French leader in dressing, inaugurated this morning their new factory in Chevigny-Saint-Sauveur, near Dijon. They were too cramped in their historic site on Petitot Street in Dijon. The decision was taken in 2001 to build a new industrial complex. It is now done. On, nearly 30.000 m(2) spread production, packaging and logistics. The company plans to become the European leader in dressing and healing within five years.
The FOURNIER Group, owner of the URGO brand of dressings, established itself in Eastern Europe by acquiring a majority stake in the Czech company MEDCOM. Interview with Bernard MAJOIE, CEO of FOURNIER laboratories.
The Industrial site of Urgo employs 50 employees on 6000 square meters Innovation with therapeutic dressings. Around 15 patents filed in 2012 and more than 200 references manufactured on the site, the company shows a growth of 10%, 2% are allocated to research and development. The activity of the Veauche site is also oriented towards export Great Britain, Germany, Netherlands, Vietnam and China.
Report on the development of the Urgo group, originally a small French and family business, which has only grown. Interviews with Briac LE LOUS, head of the consumer health subsidiary, Hervé LE LOUS, group CEO and Guirec LE LOUS, President of UrgoTech.
The Ministry of Health changed the advertisement for the Sédasteréril bandage sold in the supermarket because it indicated that it contained an antiseptic, implying that the bandage would be a drug, therefore only for sale in pharmacies. Reaction of Hervé LE LOUS, CEO S.E.D and Itw de Didier FARJAUDON (pharmacist): "our goal is public health".
Interview with Jean LE LOUS, President and Chief Executive Officer of FOURNIER Laboratories about the authoritarian price cut of 250 drugs decided by the government. Jean LE LOUS discusses the savings measures that this reduction will bring and in particular the reduction of research costs.